Yes, I read this. Interestingly, the trial will only take 12 weeks, so this stock could move quickly before EOY. SP is cheap, given huge market for acne. Avoids systemic side effects of minocycline/Accutane, potentially. Should be on everyone's radar who follows biotechs, IMHO.